Evidence map›Paper›PMID 33580313›Full record

ReviewBiomechanics and modeling in mechanobiology2021

Precision medicine in human heart modeling : Perspectives, challenges, and opportunities.

M Peirlinck, F Sahli Costabal, J Yao, J M Guccione, S Tripathy, Y Wang, D Ozturk, P Segars, T M Morrison, S Levine and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Biomechanics and modeling in mechanobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 2 pooled it
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Constitutive discovery in the living human heart.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

M PeirlinckDepartment of Mechanical Engineering, Stanford University, Stanford, California, USA.ORCID http://orcid.org/0000-0002-4948-5585
F Sahli CostabalDepartment of Mechanical Engineering, Pontificia Universidad Catholica de Chile, Santiago, Chile.
J YaoDassault Systèmes Simulia Corporation, Johnston, Rhode Island, USA.
J M GuccioneUniversity of California, San Francisco, California, USA.
S TripathyEdwards Lifesciences, Irvine, California, USA.
Y WangThornton Tomasetti Inc., Santa Clara, California, USA.
D OzturkCapvidia, Leuven, Belgium.
P SegarsCarl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University, Durham, North Carolina, USA.
T M MorrisonCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
S LevineDassault Systèmes Simulia Corporation, Johnston, Rhode Island, USA.
E KuhlDepartments of Mechanical Engineering and Bioengineering, Stanford University, Stanford, California, USA. ekuhl@stanford.edu.ORCID http://orcid.org/0000-0002-6283-935X
Dassault Systèmes (United States) · USStanford University · USDuke University · USEdwards Lifesciences (United States) · USPontificia Universidad Católica de Chile · CLThornton Tomasetti (United States) · USUnited States Food and Drug Administration · USUniversity of California, San Francisco · US

Funding

Multi-Scale Laws of Myocardial Growth and RemodelingU01HL119578 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUCCIONE, JULIUS MATTEO, KASSAB, GHASSAN S · 2014 to 2018
$3.8M
Precision Cardiac CT: Development of a Computational Platform for Optimizing ImagingR01HL131753 · NHLBI · DUKE UNIVERSITY · PI SAMEI, EHSAN, SEGARS, WILLIAM P · 2017 to 2020
$2.7M
Multi-Scale Model of the Human Heart for Imaging ResearchR01HL091036 · NHLBI · DUKE UNIVERSITY · PI SEGARS, WILLIAM P · 2009 to 2012
$2.1M
ANID Nucleus on Cardiovascular Magnetic Resonance of the Millennium Science InitiativeBAEF Postdoctoral Research FellowshipFONDECYT Postdoctorado 3190355NHLBI NIH HHS R01 HL091036NHLBI NIH HHS R01 HL131753NHLBI NIH HHS U01 HL119578NIH HHS R01 HL131753NIH HHS U01 HL119578PIA ACT192064Stanford BioX IIP Seed Grant
6 · The paper itself

Abstract

Precision medicine is a new frontier in healthcare that uses scientific methods to customize medical treatment to the individual genes, anatomy, physiology, and lifestyle of each person. In cardiovascular health, precision medicine has emerged as a promising paradigm to enable cost-effective solutions that improve quality of life and reduce mortality rates. However, the exact role in precision medicine for human heart modeling has not yet been fully explored. Here, we discuss the challenges and opportunities for personalized human heart simulations, from diagnosis to device design, treatment planning, and prognosis. With a view toward personalization, we map out the history of anatomic, physical, and constitutive human heart models throughout the past three decades. We illustrate recent human heart modeling in electrophysiology, cardiac mechanics, and fluid dynamics and highlight clinically relevant applications of these models for drug development, pacing lead failure, heart failure, ventricular assist devices, edge-to-edge repair, and annuloplasty. With a view toward translational medicine, we provide a clinical perspective on virtual imaging trials and a regulatory perspective on medical device innovation. We show that precision medicine in human heart modeling does not necessarily require a fully personalized, high-resolution whole heart model with an entire personalized medical history. Instead, we advocate for creating personalized models out of population-based libraries with geometric, biological, physical, and clinical information by morphing between clinical data and medical histories from cohorts of patients using machine learning. We anticipate that this perspective will shape the path toward introducing human heart simulations into precision medicine with the ultimate goals to facilitate clinical decision making, guide treatment planning, and accelerate device design.

Indexed as

Models, CardiovascularPrecision MedicineBiomechanical PhenomenaClinical Trials as TopicElectrophysiological PhenomenaHeartHumansCardiac mechanicsDigital twinElectrophysiologyFinite element simulationFluid dynamicsMachine learningPrecision medicine

Identifiers

PMID33580313
PMCPMC8154814
OpenAlexW3126298892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.